Fri, September 28, 2012
[ Fri, Sep 28th 2012 ]: Market Wire
Insmed Announces Pricing of Approximately $26 Million Direct Public Offering
[ Fri, Sep 28th 2012 ]: Market Wire
IsoRay, Inc. Reports Fiscal Year 2012 Results
[ Fri, Sep 28th 2012 ]: Market Wire
Biotech Industry Look to Benefit From the Introdu .. Technology Small Business Research Incentives Act
[ Fri, Sep 28th 2012 ]: Market Wire
Dynatronics Announces Fourth Quarter and Year-End Results
[ Fri, Sep 28th 2012 ]: Market Wire
Idera Pharmaceuticals to Present at the 3rd Annual Cancer Immunotherapy Conference
[ Fri, Sep 28th 2012 ]: Market Wire
Cytomedix Announces Poster Presentation at Britis .. thetic Plastic Surgeons Annual Scientific Meeting
[ Fri, Sep 28th 2012 ]: Market Wire
A.P. Pharma Resubmits New Drug Application for AP .. the Prevention of Chemotherapy-Induced Nausea an
[ Fri, Sep 28th 2012 ]: Market Wire
Where We Are Headed - New Outlook on Alere Inc. and PerkinElmer, Inc.
[ Fri, Sep 28th 2012 ]: Market Wire
Cytori Awarded Contract Valued up to $106 Million .. arch and Development Authority (BARDA) to Develop
[ Fri, Sep 28th 2012 ]: Market Wire
AVEO and Astellas Announce Submission of New Drug .. or the Treatment of Advanced Renal Cell Carcinoma
[ Fri, Sep 28th 2012 ]: Market Wire
Shareholder Rights Law Firm Johnson & Weaver, LLP .. uestcor Pharmaceuticals Inc. for Securities Fraud
[ Fri, Sep 28th 2012 ]: Market Wire
Swissmedic Invokes Rapid Authorization Procedures for Prochymal Review
[ Fri, Sep 28th 2012 ]: Market Wire
Oncolytics Biotech Inc. Announces the Appointment of Dr. Alan J. Tuchman as Chief Medical Officer
[ Fri, Sep 28th 2012 ]: Market Wire
EYLEA (aflibercept) Injection Approved for the Tr .. of Wet Age-Related Macular Degeneration in Japan
[ Fri, Sep 28th 2012 ]: Market Wire
Boston Scientific Launches Vercisea" Deep Brain Stimulation System in Europe
[ Fri, Sep 28th 2012 ]: Market Wire
Unprecedented progression-free survival benefit w .. clinically meaningful improvements in life-limit
Thu, September 27, 2012
[ Thu, Sep 27th 2012 ]: Market Wire
Boston Scientific Launches Emergea" PTCA Balloon Dilatation Catheter in the U.S.
[ Thu, Sep 27th 2012 ]: Market Wire
Oral Arguments in the UCSF Appeal of United State .. Judgment in Favor of InSite Vision Are Scheduled
[ Thu, Sep 27th 2012 ]: Market Wire
New Legislation and Major Patent Expirations Cont .. uting Factors to Biotech Industry Success in 2012
[ Thu, Sep 27th 2012 ]: Market Wire
BioLineRx Enters into Share Purchase Agreement with Lincoln Park Capital
[ Thu, Sep 27th 2012 ]: Market Wire
Peregrine Pharmaceuticals Announces New Location of Annual Meeting of Stockholders
[ Thu, Sep 27th 2012 ]: Market Wire
A Refreshing Outlook - Consensus Reports on UnitedHealth Group Incorporated and Health Net Inc.
[ Thu, Sep 27th 2012 ]: Market Wire
FDA Clears Life Technologies' OpTmizera" T-Cell Growth Medium for Use in Clinical Trials
[ Thu, Sep 27th 2012 ]: Market Wire
Horizon Pharma to Present at the 11th Annual BIO Investor Forum
[ Thu, Sep 27th 2012 ]: Market Wire
AspenBio Plans to Initiate Pivotal Study in Fourth Quarter
[ Thu, Sep 27th 2012 ]: Market Wire
A Refreshing Outlook - Consensus Reports on Aetna Inc. and Coventry Health Care, Inc.
[ Thu, Sep 27th 2012 ]: Market Wire
Knome Introduces the knoSYS™100; Fi .. Plug-and-Play Human Genome Interpretation System
[ Thu, Sep 27th 2012 ]: Market Wire
BioLineRx Announces Publication of EAGLE Study Re .. Efficacy in Improving Cognitive Function in Schi
[ Thu, Sep 27th 2012 ]: Market Wire
Arnold C. Hanish Elected to Board of Directors of Omeros
[ Thu, Sep 27th 2012 ]: Market Wire
Provectus Expands Protocol for Phase 1 Liver Cancer Study
[ Thu, Sep 27th 2012 ]: Market Wire
Dr. Reddy’s Announces the Launch of Montelukast Sodium Oral Granules
[ Thu, Sep 27th 2012 ]: Market Wire
Syneron anuncia el lanzamiento global de Gentle P .. ual de la European Academy of Dermatology and Ven
Wed, September 26, 2012
[ Wed, Sep 26th 2012 ]: Market Wire
Graphite Corp. Sampling at Alabama Property Validates Data and Initiates October Fieldwork
[ Wed, Sep 26th 2012 ]: Market Wire
Where We Are Headed - New Outlook on Forest Labor .. , Inc. and Teva Pharmaceutical Industries Limited
[ Wed, Sep 26th 2012 ]: Market Wire
Critical Alerts For Amgen, Tyco, SanDisk, Lam Research, and Eaton Released By InvestorsObserver
[ Wed, Sep 26th 2012 ]: Market Wire
LED Medical Diagnostics Inc. Announces Strategic Alliance With DenMat Holdings LLC
[ Wed, Sep 26th 2012 ]: Market Wire
Janssen and Johnson amp;; Johnson to Prese .. r Canagliflozin in the Treatment of Patients with
[ Wed, Sep 26th 2012 ]: Market Wire
Aethlon Medical Announces the Appointment of Dr. .. adem to its Extracorporeal Science Advisory Board
[ Wed, Sep 26th 2012 ]: Market Wire
Unigene to Target Partnering and Therapeutic Deve .. ng Victory Park Capital Debt Financing and Forbea
[ Wed, Sep 26th 2012 ]: Market Wire
GNS Healthcare and Aetna Using quot;;Big D .. tics to Help Prevent Heart and Metabolic Diseases
[ Wed, Sep 26th 2012 ]: Market Wire
Major Pharmaceutical Stocks Rise After Moody's Upgrades Industry to "Stable"
[ Wed, Sep 26th 2012 ]: Market Wire
Pfizer and GlaxoSmithKline Rise After Moody's Upgrades Pharmaceutical Industry Outlook to "Stable"
[ Wed, Sep 26th 2012 ]: Market Wire
Medicure Announces Development of Novel AGGRASTAT Formulation
[ Wed, Sep 26th 2012 ]: Market Wire
Threshold Pharmaceuticals Announces Presentations .. 302 in Pancreatic Cancer and Glioblastoma at ESMO
[ Wed, Sep 26th 2012 ]: Market Wire
BIOGEN IDEC AND SOBI ANNOUNCE POSITIVE TOP-LINE R .. VESTIGATING LONG-LASTING RECOMBINANT FACTOR IX FC
[ Wed, Sep 26th 2012 ]: Market Wire
Uroplasty Announces Coverage of Percutaneous Tibi .. s Urgent PC Neuromodulation System by ConnectiCar
[ Wed, Sep 26th 2012 ]: Market Wire
Frederic Chereau Joins Shire Human Genetic Therapies to Lead Angioedema Franchise
[ Wed, Sep 26th 2012 ]: Market Wire
VentriPoint to Present at the 2012 Aegis Healthcare Conference

Horizon Pharma to Present at the 11th Annual BIO Investor Forum

September 27, 2012 07:30 ET

Horizon Pharma to Present at the 11th Annual BIO Investor Forum

DEERFIELD, IL--(Marketwire - Sep 27, 2012) - Horizon Pharma, Inc. (NASDAQ: [ HZNP ]) today announced that Todd Smith, executive vice president and chief commercial officer, will present at the 11th Annual BIO Investor Forum on Tuesday, October 9, 2012 at 4:30 p.m. Pacific Time (7:30 p.m. Eastern Time) in San Francisco, CA. Mr. Smith will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at
[ http://ir.horizon-pharma.com ]. 

About Horizon Pharma
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit [ www.horizonpharma.com ].